Imaging cell death.

Area of Science:

• Biomedical imaging
• Molecular imaging
• Oncology

Background:

• Clinical need for non-invasive methods to detect cell death in tissues.
• Early detection of therapy-induced tumor cell death is essential for treatment monitoring.
• Currently, no approved probes exist for routine clinical imaging of cell death.

Purpose of the Study:

• To review cell death imaging probes with clinical trial data or significant preclinical promise.
• To identify clinically relevant hallmarks of cell death for biomarker development.
• To bridge the gap between preclinical research and clinical application of cell death imaging.

Main Methods:

• Literature review of cell death imaging probes.
• Analysis of probes based on clinical trial status and preclinical validation.
• Focus on probes targeting specific hallmarks of cell death.

Main Results:

• Several cell death imaging probes show promise for clinical translation.
• Probes targeting apoptosis and other cell death modalities are under investigation.
• Preclinical data highlights the potential of specific molecular targets.

Conclusions:

• Validated cell death imaging probes are needed for routine clinical use.
• Ongoing research is advancing the development of effective imaging biomarkers for cell death.
• Future clinical applications may include early diagnosis and therapy response assessment.